 The population-based retrospective cohort study looked at rates of adverse events involving cerebral thromboembolism, brain blood clots, following injection from COVID shots. It includes the data from the Vaccine Adverse Events Reporting System database, which is managed by the U.S. Centers for Disease Control, CDC, and Quasi-Prevention, and the U.S. Food and Drug Administration, FDA.